CD19 and plasma cell neoplasm: Our preliminary data showed the frequencies of CD19+CD24hiCD38hi Bregs within CD19+ B cells significantly varied among different disease subtypes of plasma cell neoplasms; and the patients at early stage had significantly higher levels of Bregs' ratios than at late stage.